Skip to main content
. 2018 May 7;20(6):952–962. doi: 10.1007/s11307-018-1201-3

Table 1.

A summary of the radiotracers and modalities used in this study

Radiotracer Abbreviation Modality Putative alteration/process
[99m Tc][2,2-dimethyl-3-[(3E)-3-oxidoiminobutan-2-yl]azanidylpropyl]-[(3E)-3-hydroxyiminobutan-2-yl]azanide [99mTc]HMPAO SPECT Brain perfusion [22]
ethyl 7-[125I]iodo-5-methyl-6-oxo-4H-imidazol[1,5-a][1,4]benzodiazepine-3-carboxylate [125I]iomazenil SPECT Neuronal damage/apoptosis [23–26]
2-[6-chloro-2-(4-[125I]iodophenyl)-imidazo[1,2-a]pyridin-3-yl]-N-ethyl-N-methyl-acetamide [125I]CLINME SPECT Microglia activation [27]
2-deoxy-2-[18F]fluoro-D-glucose [18F]FDG PET Cerebral glucose uptake [28]

SPECT: single photon emission computed tomography, PET: positron emission tomography.